ComInnex has announced that Alex Drijver has joined the company as CEO.
Mr Drijver brings over 14 years of in the service sector of early stage pharmaceutical discovery research and joins from ChemAxon, which over the last 7 years he helped to build into one of the fastest growing and leading global cheminformatics companies. Prior to ChemAxon Mr. Drijver was CEO at ThalesNano, an innovative laboratory instrumentation company, and CFO of ComGenex, the largest privately held European chemistry services company prior to its sale to AMRI.
"We are very excited to have someone of Alex's proven track-record in business building join our team. ComInnex already has long term contracts with a number of major pharmaceutical companies and Alex will be crucial in developing our medium and long term business strategies forward. He is supported by an excellent technical team with novel and innovative chemistry ideas and solutions," said Dr. Ferenc Darvas, President of ComInnex.
"ComInnex has game-changing solutions through its technology based approach to design and synthesis, which is already validated through the existing projects. It is very exciting for me to come into this environment at this stage of the company's development and I look forward to working with the team to enable better science and improved drug research for our customers. Outsourcing and collaboration are the key drivers in pharmaceutical research today and our challenge is to meet the high standards and needs of an industry increasingly driven by technology," added Mr. Drijver, who was previously also a Board Member at the Pistoia Alliance, a cross industry initiative to reduce barriers to innovation in pharmaceutical research IT.
ComInnex is a specialist chemistry research organization that collaborates with pharmaceutical and biotechnology companies as well as academic and non-profit institutions to advance drug discovery through smarter chemistry. ComInnex has developed a proprietary technology platform encompassing both hardware and software that enables out-of-the box thinking and the exploration of new chemical spaces.